Melanocytic nevi in children treated with growth hormone

Pediatrics

Volumn 104, Issue 4 II, 1999, Pages 1045-1049

  Wyatt, David ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Acquired melanocytic nevi; Growth hormone; Melanoma; Noonan Syndrome; Turner syndrome

Indexed keywords

GROWTH HORMONE;

ACROMEGALY; ADOLESCENT; CANCER RISK; CHILD; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOCYTIC NEVUS; PRIORITY JOURNAL; SHORT STATURE; SKIN CANCER; TURNER SYNDROME;

CHILD; FEMALE; GROWTH DISORDERS; GROWTH HORMONE; HUMANS; MALE; NEVUS, PIGMENTED; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TURNER SYNDROME;

EID: 0032829522     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (24)

1. Bourguignon J-P, Piérard GE, Ernould C, et al. Effects of human growth hormone therapy on melanocytic naevi. Lancet. 1993;341:1505-1506
2. Blethen SL, Allen DB, Graves D, August G, Moshang T, Rosenfeld R. Safety of recombinant deoxyribonucleic acid-derived growth hormone: the National Cooperative Growth Study experience. J Clin Endocrinol Metab. 1996;81:1704-1710
3. Allen DB. Safety of human growth hormone therapy: current topics. J Pediatr. 1996;128:S8-S13
4. Swerdlow AJ, English J, MacKie RM, et al. Benign melanocytic naevi as a risk factor for malignant melanoma. Br J Med. 1986;292:1555-1559
5. Orme SM, McNally RJQ, Cartwright RA, Belchetz PE. Mortality and cancer incidence in acromegaly: a retrospective cohort study. J Clin Endocrinol Metab. 1998;83:2730-2734
6. Nabarro JDN. Acromegaly. Clin Endocrinol. 1987;26:481-512
7. Wright AD, Hill DM, Lowy C, Fraser TR. Mortality in acromegaly. Q J Med. 1970;39:1-16
8. Rajasoorya C, Holdaway IM, Wrightson P, Scott DJ, Ibbertson HK. Determinants of clinical outcome and survival in acromegaly. Clin Endocrinol. 1994;41:95-102
9. Bengtsson BA, Edén S, Ernest I, Oden A, Sjögren B. Epidemiology and long-term survival in acromegaly: a study of 166 cases diagnosed between 1955 and 1984. Acta Med Scand. 1988;223:327-335
10. Ezzat S, Melmed S. Are patients with acromegaly at increased risk for neoplasia? J Clin Endocrinol Metab. 1991;72:245-249
11. Molitch ME. Clinical manifestations of acromegaly. Endocrinol Metab Clin North Am. 1992;21:597-614
12. Barzilay J, Heatley GJ, Cushing GW. Benign and malignant tumors in patients with acromegaly. Arch Intern Med. 1991;151:1629-1632
13. Alexander L, Appleton D, Hall R, Ross WM, Wilkinson R. Epidemiology of acromegaly in the Newcastle region. Clin Endocrinol. 1980;12: 71-79
14. Hall G, Gilchrist DM. Turner syndrome and its variants. Pediatr Clin North Am. 1990;37:1421-1440
15. Zvulunov A, Wyatt DT, Laud PW, Esterly NB. Lack of effect of growth hormone therapy on the count and density of melanocytic naevi in children. Br J Dermatol. 1997;137:545-548
16. Zvulunov A, Wyatt DT, Laud PW, Esterly NB. Influence of genetic and environmental factors on melanocytic naevi: a lesson from Turner's syndrome. Br J Dermatol. 1998;138:993-997
17. Zvulunov A, Wyatt DT, Rabinowitz LG, Esterly NB. Effect of growth hormone therapy on melanocytic nevi in survivors of childhood neoplasia. Arch Dermatol. 1997;133:795-796
18. Gallagher RP, McLean DI, Yang CP, et al. Anatomic distribution of acquired melanocytic nevi in white children. Arch Dermatol. 1990;126: 466-471
19. Williams-Blangero S, Blangero J. Quantitative genetic analysis of skin reflectance: a multivariate approach. Hum Biol. 1992;64:35-49
20. Williams ML, Pennella R. Melanoma, melanocytic nevi, and other melanoma risk factors in children. J Pediatr. 1994;124:833-845
21. Ries LAG, Kosary CL, Hankey BF, Harras A, Miller BA, Edwards BK, eds. SEER Cancer Statistics Review, 1973-1993: Tables and Graphs. Bethesda, MD: National Cancer Institute; 1996
22. Rockley PF, Trieff N, Wagner RF Jr, Tyring SK. Nonsunlight risk factors for malignant melanoma. II. Immunity, genetics, and workplace prevention, Int J Dermatol. 1994;33:462-467
23. Buckley CA, Cheng H. Intraocular melanoma, diabetes, and Turner's syndrome: presentation with proptosis. Br J Ophthalmol. 1981;65: 460-463
24. Gare M, Ilan Y, Sherman Y, Ben-Chetrit E. Malignant melanoma in Turner's syndrome, Int J Dermatol. 1993;32:743-744